Receptos IPO Research Information

Receptos IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Receptos, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Receptos	RCPT -	$14.00-$16.00	$14.00	$15.00	5.2 million	5/9/2013
Underwriter(s): Credit Suisse, Leerink Swann, BMO Capital Markets
Co-Manager(s): Wedbush PacGrow Life Sciences
Industry: Health Care
Filing(s): Filed 2013-04-04

Receptos Quote & Chart - Click for current quote - RCPT

About Receptos (adapted from Receptos prospectus):
They are a biopharmaceutical company focused on discovering, developing and commercializing innovative therapeutics for immune disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RCPT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.